Consistently, the expression levels and/or activities of Fyn or Src are elevated in many cancers, and the activated Fyn or Src promote epithelial–mesenchymal transition and invasion into the basement membrane (3, 9, 15, 16, 17, 18). The gene discussed is FYN; the disease is cancer.